Atlas Venture Fund V Lp - Net Worth and Insider Trading
Atlas Venture Fund V Lp Net Worth
The estimated net worth of Atlas Venture Fund V Lp is at least $10 Million dollars as of 2024-11-13. Atlas Venture Fund V Lp is the 10% Owner of NxStage Medical Inc and owns about 218,944 shares of NxStage Medical Inc (NXTM) stock worth over $7 Million. Atlas Venture Fund V Lp is also the 10% Owner of Momenta Pharmaceuticals Inc and owns about 73,201 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $4 Million. Details can be seen in Atlas Venture Fund V Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atlas Venture Fund V Lp has not made any transactions after 2005-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Atlas Venture Fund V Lp
Atlas Venture Fund V Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Fund V Lp owns 4 companies in total, including Achillion Pharmaceuticals Inc (ACHN) , Alnylam Pharmaceuticals Inc (ALNY) , and NxStage Medical Inc (NXTM) among others .
Click here to see the complete history of Atlas Venture Fund V Lp’s form 4 insider trades.
Insider Ownership Summary of Atlas Venture Fund V Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2006-10-31 | 10 percent owner |
| ALNY | Alnylam Pharmaceuticals Inc | 2004-05-27 | 10 percent owner |
| NXTM | NxStage Medical Inc | 2005-11-01 | 10 percent owner |
 | | 2005-08-03 | 10 percent owner |
Atlas Venture Fund V Lp Latest Holdings Summary
Atlas Venture Fund V Lp currently owns a total of 2 stocks. Among these stocks, Atlas Venture Fund V Lp owns 218,944 shares of NxStage Medical Inc (NXTM) as of October 27, 2005, with a value of $7 Million and a weighting of 63.1%. Atlas Venture Fund V Lp also owns 73,201 shares of Momenta Pharmaceuticals Inc (MNTA) as of June 21, 2004, with a value of $4 Million and a weighting of 36.9%.
Latest Holdings of Atlas Venture Fund V Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NXTM | NxStage Medical Inc | 2005-10-27 | 218,944 | 30.00 | 6,568,320 |
| MNTA | Momenta Pharmaceuticals Inc | 2004-06-21 | 73,201 | 52.48 | 3,841,588 |
Holding Weightings of Atlas Venture Fund V Lp
Atlas Venture Fund V Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Atlas Venture Fund V Lp has made a total of 0 transactions in NxStage Medical Inc (NXTM) over the past 5 years. The most-recent trade in NxStage Medical Inc is the acquisition of 99,923 shares on October 27, 2005, which cost Atlas Venture Fund V Lp around $999,230.
According to the SEC Form 4 filings, Atlas Venture Fund V Lp has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the acquisition of 244,000 shares on June 21, 2004, which cost Atlas Venture Fund V Lp around $2 Million.
Insider Trading History of Atlas Venture Fund V Lp
- 1
Atlas Venture Fund V Lp Trading Performance
GuruFocus tracks the stock performance after each of Atlas Venture Fund V Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Atlas Venture Fund V Lp is 1.02%. GuruFocus also compares Atlas Venture Fund V Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Atlas Venture Fund V Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Atlas Venture Fund V Lp's insider trading performs compared to the benchmark.
Performance of Atlas Venture Fund V Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.33 | | | | | |
| Relative Return to S&P 500(%) | 8.75 | | | | | |
Atlas Venture Fund V Lp Ownership Network
Ownership Network List of Atlas Venture Fund V Lp
Ownership Network Relation of Atlas Venture Fund V Lp
Atlas Venture Fund V Lp Owned Company Details
What does Achillion Pharmaceuticals Inc do?
Who are the key executives at Achillion Pharmaceuticals Inc?
Atlas Venture Fund V Lp is the 10 percent owner of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , EVP & Chief Medical Officer Steven Zelenkofske , and General Counsel Martha E Manning .
Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achillion Pharmaceuticals Inc Insider Transactions
Atlas Venture Fund V Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Fund V Lp. Currently GuruFocus does not have mailing address information for Atlas Venture Fund V Lp.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
